Alzheimer Disease
📧 Sign up to get email alerts when something new happens for Alzheimer Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2010-10-19Clinical Trial Update: Safety/Tolerability, Immunological and Clinical Activity of a Boost Immunization With AFFITOPE AD02 [Phase 1]
A Phase 1 trial evaluating the safety, tolerability, immune response, and clinical activity of a booster immunization with AFFITOPE AD02 in …
-
CLINICAL_TRIALS trial_result · 2010-10-19Clinical Trial Update: Tolerability and Safety of Subcutaneous Administration of AFFITOPE AD02 in Mild to Moderate Alzheimer's Disease [Phase 1]
Phase 1 study evaluating tolerability and safety of subcutaneous AFFITOPE AD02 in individuals with mild to moderate Alzheimer's disease; the…
-
CLINICAL_TRIALS trial_result · 2010-10-06Clinical Trial Update: Evaluation of [123I] AV151 and SPECT in Subjects w/ AD in Comparison to Healthy Subjects [Phase 1]
Phase 1 evaluation of the radiotracer [123I] AV151 for SPECT imaging in Alzheimer's disease subjects compared to healthy controls; the trial…
-
CLINICAL_TRIALS trial_result · 2010-10-06Clinical Trial Update: Safety and Efficacy of Positron Emission Tomography Imaging With MNI-513 [EARLY_Phase 1]
An EARLY_PHASE1 clinical trial evaluating the safety and efficacy of the PET imaging agent MNI-513 for Alzheimer's disease has been terminat…
-
CLINICAL_TRIALS trial_result · 2010-10-06Clinical Trial Update: Evaluation of [123I] AV94 and SPECT in Subjects With Alzheimer Disease in Comparison to Healthy Subjects [Phase 1]
Phase 1 study evaluating the radiolabeled imaging agent AV94 with SPECT in individuals with Alzheimer disease compared to healthy controls; …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2010-09-16Clinical Trial Update: A Study of the Safety and Efficacy of Memantine in Moderate to Severe Alzheimer's Disease [Phase 3]
A Phase 3 study evaluating memantine for moderate to severe Alzheimer's disease has completed, with results posted in 2010.
-
CLINICAL_TRIALS trial_result · 2010-09-16Clinical Trial Update: Ginkgo Biloba Prevention Trial in Older Individuals [Phase 3]
A Phase 3 clinical trial investigating Ginkgo Biloba for prevention of dementia in older individuals has completed and posted results.
-
CLINICAL_TRIALS trial_result · 2010-09-08Clinical Trial Update: Donepezil Treatment of Psychotic Symptoms in Dementia Patients [Phase 3]
A Phase 3 trial assessing donepezil for treating psychotic symptoms in Alzheimer's-type dementia is described, with the current status not r…
-
CLINICAL_TRIALS trial_result · 2010-08-30Clinical Trial Update: DHA (Docosahexaenoic Acid), an Omega 3 Fatty Acid, in Slowing the Progression of Alzheimer's Disease [Phase 3]
A Phase 3 trial evaluating DHA (docosahexaenoic acid) for slowing progression of Alzheimer's disease has completed. The results were posted …
-
CLINICAL_TRIALS trial_result · 2010-08-30Clinical Trial Update: Bioequivalence Study of Galantamine 4 mg Tablet and Reminyl Following a 4 mg Dose in Healthy Subjects Under Fed Conditions [Phase 1]
Phase 1 bioequivalence study comparing a 4 mg galantamine tablet to Reminyl under fed conditions in healthy subjects; the study has complete…
-
FDA approval · 2010-08-27FDA Approved: RIVASTIGMINE — Supplemental Application (Sandoz Inc)
FDA approved a supplemental application for rivastigmine submitted by Sandoz Inc under NDA022083.
-
CLINICAL_TRIALS trial_result · 2010-08-25Clinical Trial Update: Project TAP: Tailored Activities Project [Phase 1]
A completed Phase 1 clinical trial evaluating the Tailored Activities Project for Alzheimer's disease.
-
CLINICAL_TRIALS trial_result · 2010-08-19Clinical Trial Update: Effect of Testosterone Therapy in Men With Alzheimer's Disease and Low Testosterone [NA]
This entry notes the completion of a clinical trial evaluating testosterone therapy in men with Alzheimer's disease who have low testosteron…
-
CLINICAL_TRIALS trial_result · 2010-08-13Clinical Trial Update: Improved Diagnosis of Alzheimer's Disease Using Magnetoencephalography (MEG)
A completed trial reports that magnetoencephalography (MEG) may improve the diagnosis of Alzheimer's disease.
-
CLINICAL_TRIALS trial_result · 2010-08-13Clinical Trial Update: Building Better Caregivers Online: An Online Workshop for Caregivers of Those With Traumatic Brain Injury, Post Traumatic Stress Disorder, or Alzheimer's or Other Dementia [Phase 1]
A Phase 1 online caregiving workshop trial for caregivers of people with dementia, traumatic brain injury, or post-traumatic stress disorder…
-
CLINICAL_TRIALS trial_result · 2010-08-13Clinical Trial Update: Improved Diagnosis of Alzheimer's Disease Using the Synchronous Neural Interaction™ Test
Completed clinical trial evaluating the Synchronous Neural Interaction Test for improved diagnosis of Alzheimer's disease.
-
CLINICAL_TRIALS trial_result · 2010-08-11Clinical Trial Update: 4 Week, Safety and Tolerability Study in Patients With Mild to Moderate Alzheimer's Disease [Phase 2]
Phase 2 safety and tolerability results from a 4-week study in patients with mild-to-moderate Alzheimer's disease, sponsored by AstraZeneca.
-
CLINICAL_TRIALS trial_result · 2010-08-03Clinical Trial Update: Quality Of Life Assessment In Alzheimer's Disease (AD) Patients Receiving Aricept Tablets
A Pfizer-sponsored trial evaluated quality of life in Alzheimer's disease patients treated with Aricept; results were posted in 2010.
-
CLINICAL_TRIALS research · 2010-07-26Clinical Trial Update: Evolution of Memory Related Activity
Clinical trial update on memory-related activity involving Alzheimer's disease and mild cognitive impairment; current status is unknown.
-
FDA approval · 2010-07-23FDA Approved: ARICEPT — Original Application (Eisai Inc.)
FDA approved ARICEPT (donepezil hydrochloride) under an original application by Eisai Inc. for the treatment of Alzheimer's disease. The ent…
-
CLINICAL_TRIALS trial_result · 2010-07-20Clinical Trial Update: Treatment of Language and Memory in Patients With Alzheimer's Disease [Phase 1]
Phase 1 clinical trial assessing a treatment for language and memory deficits in Alzheimer's disease has completed, with results posted in 2…
-
CLINICAL_TRIALS research · 2010-07-16Clinical Trial Update: Encapsulated Cell Biodelivery of Nerve Growth Factor to Alzheimer´s Disease Patients [Phase 1]
Phase 1 clinical trial evaluating encapsulated cell biodelivery of nerve growth factor for Alzheimer's disease patients.
-
CLINICAL_TRIALS trial_result · 2010-07-13Clinical Trial Update: Effects of Transcranial Magnetic Stimulation (TMS) and Cognitive Training for Alzheimer Patients [NA]
A completed clinical trial evaluating transcranial magnetic stimulation and cognitive training in patients with early-onset Alzheimer's dise…
-
CLINICAL_TRIALS trial_result · 2010-07-07Clinical Trial Update: Safety and Feasibility of Sodium Oxybate in Mild Alzheimer's Disease Patients [Phase 4]
A Phase 4 study evaluating the safety and feasibility of sodium oxybate in patients with mild Alzheimer's disease has been terminated.
-
CLINICAL_TRIALS withdrawal · 2010-06-29Clinical Trial Update: A Study Of Oral PF-01913539 In Patients With Mild To Moderate Alzheimer's Disease [Phase 2]
Pfizer's Phase 2 study of the investigational drug PF-01913539 in mild-to-moderate Alzheimer's disease has been withdrawn.